Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKenmare Resources Regulatory News (KMR)

Share Price Information for Kenmare Resources (KMR)

Share Price is delayed by 15 minutes
Get Live Data
214.50    3.00 (1.42%)
Bid:
214.50
Ask:
216.00
Spread: 1.50 (0.699%)
Market Cap: £190.15m
KMR Live PriceLast checked at - London Stock Exchange

Intraday Kenmare Resources Share Chart

Form 38.5A Kenmare Resources PLC

29 Apr 2025 09:33

RNS Number : 6132G
J & E Davy Unlimited Company
29 April 2025
 

Ap34

 

FORM 38.5(a) (EPT/RI)

 

IRISH TAKEOVER PANEL

 

DEALING DISCLOSURE UNDER RULE 38.5(a) OF THE IRISHTAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022BY A CONNECTED EXEMPT PRINCIPAL TRADER WITHRECOGNISED INTERMEDIARY STATUS AND DEALING INA CLIENT-SERVING CAPACITY

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

J&E Davy Unlimited Company

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Kenmare Resources PLC

(c) Name of the party to the offer with which exempt principal trader is connected: (Note 1)

Kenmare Resources PLC

(d) Date dealing undertaken:

28/04/2025

(e) In addition to the company in 1(b) above, is the exempt principal trader also making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER (Note 2)

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

Ap35

 

(a) Purchases and sales

 

Class of relevant security (Note 3)

Purchases/ sales

Totalnumber of securities

Highest price per unit paid/ received

Lowest price per unit paid/ received

ORD EUR0.001 (CDI)

Buy

350

413.96 GBX

408 GBX

ORD EUR0.001 (CDI)

Sell

175

408 GBX

408 GBX

ORD EUR0.001

Buy

1921

4.8145 EUR

 4.8 EUR

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description e.g. CFD

Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities (Note 4)

Price perunit (Note 5)

N/A

N/A

N/A

N/A

N/A

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates (Note 4)

Exercise price per unit

Type  e.g. American, European etc.

Expirydate

Option money paid/ received per unit

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

 

(ii) Exercise

 

Class of relevant security

Product description e.g. call option

Exercising/ exercised against

Number of securities

Exercise priceper unit (Note 5)

N/A

N/A

N/A

N/A

N/A

 

(d) Other dealings (including transactions in respect of new securities)

 

Class of relevant security

Nature of dealing e.g. subscription, conversion, exercise

Details

Price per unit (if applicable) (Note 5)

N/A

N/A

N/A

N/A

 

Ap36

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

 

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 N/A

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 N/A

 

Date of disclosure:

29/04/2025

Contact name:

Kieren Kelly

Telephone number:

016148719

 

Public disclosures under Rule 38 of the Rules must be made to a Regulatory Information Service.

 

Ap37

 

NOTES ON FORM 38.5(a)

 

1. See the definition of "connected principal trader" in Rule 2.2 of Part A of the Rules.

 

2. See the definition of "dealing" in Rule 2.1 of Part A of the Rules.

 

3. See the definition of "relevant securities" in Rule 2.1 of Part A of the Rules.

 

4. See Rule 2.5(d) of Part A of the Rules.

 

5. If the economic exposure to changes in the price of securities is limited, for example, by virtue of a stop loss arrangement relating to a spread bet, full details must be given.

 

6. If details included in a disclosure under Rule 38 are incorrect, they should be corrected as soon as practicable in a subsequent disclosure. Such disclosure should state clearly that it corrects details disclosed previously, identify the disclosure or disclosures being corrected, and provide sufficient detail for the reader to understand the nature of the corrections. In the case of any doubt, the Panel should be consulted.

 

For full details of disclosure requirements, see Rules 8 and 38 of the Rules. If in doubt, consult the Panel.

 

References in these notes to "the Rules" are to the Irish Takeover Panel Act, 1997, Takeover Rules, 2022.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ITPPKCBNFBKKDQB
Date   Source Headline
11th May 20237:00 amGNWBoard Update
5th May 20235:11 pmGNWHolding(s) in Company
2nd May 202312:06 pmGNWHolding(s) in Company
26th Apr 20237:00 amGNWCapital Markets Day
18th Apr 202312:00 pmGNWNotice of AGM
12th Apr 202312:00 pmGNWDirector/PDMR Shareholding
12th Apr 20237:00 amGNWQ1 2023 Production Report
11th Apr 20239:27 amGNWDirector/PDMR Shareholding
6th Apr 20237:00 amGNWPublication of 2022 Sustainability Report
6th Apr 20237:00 amGNWPublication of 2022 Annual Report
28th Mar 20234:30 pmGNWDirector/PDMR Shareholding
23rd Mar 20232:13 pmGNWHolding(s) in Company
22nd Mar 20237:00 amGNW2022 Preliminary Results
14th Mar 20231:16 pmGNWHolding(s) in Company
13th Mar 20232:04 pmGNWHolding(s) in Company
27th Feb 20239:56 amGNWHolding(s) in Company
27th Feb 20239:54 amGNWHolding(s) in Company
26th Jan 20237:00 amGNWBoard Update
18th Jan 20237:00 amGNWQ4 2022 Production Report and 2023 Guidance
16th Jan 20236:08 pmGNWHolding(s) in Company
9th Jan 20234:21 pmGNWHolding(s) in Company
9th Jan 20233:56 pmGNWHolding(s) in Company
22nd Dec 20224:35 pmGNWHolding(s) in Company
21st Dec 20225:07 pmGNWHolding(s) in Company
14th Dec 20227:00 amGNWBoard Update
1st Dec 20222:12 pmGNWDeirdre Somers appointed independent director of Enfusion, Inc.
25th Nov 20227:00 amGNWGuidance Update
9th Nov 20221:06 pmGNWHolding(s) in Company
18th Oct 20224:43 pmGNWHolding(s) in Company
14th Oct 202211:54 amGNWHolding(s) in Company
13th Oct 20227:00 amGNWQ3 2022 Production Report
4th Oct 20229:03 amGNWResults of Odd-lot Offer
30th Sep 202212:18 pmGNWDirector/PDMR Shareholding
30th Sep 20227:00 amGNWBoard Update
28th Sep 20221:45 pmGNWDirector/PDMR Shareholding
26th Sep 20222:22 pmGNWHolding(s) in Company
31st Aug 20224:01 pmGNWHolding(s) in Company
25th Aug 20227:00 amGNWAppointment of Financial Director / Directorate Change Announcement under LR 9.6.11
24th Aug 20227:00 amGNWLaunch of Odd-lot Offer and Finalisation of Offer Price
19th Aug 20224:44 pmGNWHolding(s) in Company
17th Aug 20227:00 amGNWHalf-Yearly Financial Report for the six months to 30 June 2022 and interim dividend
21st Jul 202212:00 pmGNWHolding(s) in Company
14th Jul 20227:00 amGNWQ2 and H1 2022 Production Report
7th Jun 20227:00 amGNWDirector/PDMR Shareholding
26th May 20226:13 pmGNWResult of AGM and Board Update
26th May 20227:00 amGNWReport on Payments to Governments 2021
19th May 20227:00 amGNWFinancial Director to Retire / Directorate Change Announcement under LR 9.6.11
17th May 202210:00 amGNWHolding(s) in Company
12th May 20227:00 amGNWAnalyst and investor visit to Moma Mine
27th Apr 20229:48 amGNWDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.